|Videos|July 9, 2018
It's an Exciting Time for Mantle Cell Lymphoma
Author(s)Michael Wang, M.D.
There are many exciting advances happening in the field of mantle cell lymphoma.
Advertisement
It is an exciting time for mantle cell lymphoma (MCL), with new treatments being explored that will lead to better patient outcomes, according to Michael Wang, M.D., professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center.
Progress is being made in targeted therapies, immunotherapy and cell therapies, according to Wang, who said that in his lifetime, there might be a percentage of patients who are cured of the disease.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Advisory Committee Backs RP1 for Advanced Melanoma
2
Same-Day Discharge and Single-Incision Surgery Are Changing Rectal Cancer Care
3
Living With Lung Cancer, Not Dying From It: One Survivor's Story of Hope
4
Why a Two-Drug Combination Could Change Myeloma Treatment
5